Elektrofi bags $40m funding to establish manufacturing line

URLhttps://bioprocessintl.com/bioprocess-insider/faci
SourceBio Process International
Date Published06/20/2022
Author Name Millie Nelson
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Elektrofi
Parent companyElektrofi
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2022
Domestically, the work will be done:In-house
Capital investment ($):40
City reshored to:Boston
State(s) reshored to:MA
If relevant, work nearshored to:-
Industry(ies):Chemicals, Wood & Paper Products
Product(s) reshoredbiotech, drug formulation
What domestic positive factors made reshoring more attractive?Other, $40m funding from Marshall Wace and BVF Partners
Find Reshoring Articles